Gilpatrick, Timothy
Lee, Isac
Graham, James E.
Raimondeau, Etienne
Bowen, Rebecca
Heron, Andrew
Downs, Bradley
Sukumar, Saraswati http://orcid.org/0000-0002-5656-6703
Sedlazeck, Fritz J http://orcid.org/0000-0001-6040-2691
Timp, Winston http://orcid.org/0000-0003-2083-6027
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (HG009190, HG009190, HG009190)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute
Article History
Received: 4 June 2019
Accepted: 6 January 2020
First Online: 10 February 2020
Competing interests
: J.G., E.R., R.B. and A.H. are employees of Oxford Nanopore Technologies. W.T. has two patents licensed to Oxford Nanopore Technologies (US patent nos. 8,748,091 and 8,394,584). T.G., I.L., F.S. and W.T. have received travel funds to speak at symposia organized by Oxford Nanopore Technologies.